Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents

Microbiology and Immunology

Volumn 40, Issue 11, 1996, Pages 821-825

  Wakabayashi, Hiroyuki ^a   Abe, Shigeru ^b   Okutomi, Takafumi ^b   Tansho, Shigeru ^b   Kawase, Kouzou ^a   Yamaguchi, Hideyo ^b  

^a MORINAGA MILK INDUSTRY CO LTD   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

Azole antifungal agents; Candida albicans; Lactoferricin ; Lactoferrin

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CLOTRIMAZOLE; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; LACTOFERRICIN B; LACTOFERRIN; NYSTATIN; PEPTIDE DERIVATIVE; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CULTURE MEDIUM; DILUTION; DRUG POTENTIATION; FUNGUS CULTURE; FUNGUS GROWTH; GROWTH INHIBITION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

CANDIDA; CANDIDA ALBICANS; FUNGI;

EID: 0030457861     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1996.tb01147.x     Document Type: Article

References (16)

1. Ballow, M., Donshik, P.C., Rapacz, P., and Samartino, L. 1987. Tear lactoferrin levels in patients with external inflammatory ocular disease. Invest. Ophthalmol. Vis. Sci. 28: 543-545.
2. Bellamy, W., Takase, M., Yamauchi, K., Wakabayashi, H., Kawase, K., and Tomita, M. 1992. Identification of bactericidal domain of lactoferrin. Biochim. Biophys. Acta 121: 130-136.
3. Bellamy, W., Wakabayashi, H., Takase, M., Kawase, K., Shimamura, S., and Tomita, M. 1993. Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin. Med. Microbiol. Immunol. 182: 97-105.
4. Eliopoulos, G.M., and Moellering, R.C. 1991. Antimicrobial combinations, p.432-492. In Lorian, V. (ed), Antibiotics in laboratory medicine, 3rd ed, Williams & Wilkins, Baltimore.
5. Kirkpatrick, C.H., Green, I., Rich, R.R., and Shade, A.L. 1971. Inhibition of growth of Candida albicans by iron-unsaturated lactoferrin: relation to host-defense mechanisms of chronic mucocutaneous candidiasis. J. Infect. Dis. 124: 539-544.
6. Li, Y.M., Tan, A.X., and Vlassara, H. 1995. Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycation-modified proteins to a conserved motif. Nature Med. 1: 1057-1061.
7. Masson, P.L., Heremans, J.F., and Dive, C.H. 1966. An iron-binding protein common to many external secretions. Clin. Chim. Acta 14: 735-739.
8. Miyazaki, S., Harada, Y., Tsuji, A., and Goto, S. 1991. In vivo combined effects of lactoferrin (LF) and drugs on bacterial infections in mice. Chemotherapy 39: 829-835 (in Japanese).
9. Nagasawa, T., Kiyosawa, I., and Kuwahara, K. 1972. Amounts of lactoferrin in human colostrum and milk. J. Dairy Sci. 55: 1651-1659.
10. Naidu, A.S., and Arnold, R.R. 1994. Lactoferrin interaction with Salmonellae potentiates antibiotic susceptibility in vitro. Diagn. Microbiol. Infect. Dis. 20: 69-75.
11. Odds, F.C. 1993. Resistance of yeasts to azole-derivative antifungal agents. J. Antimicrob. Chemother. 31: 463-471.
12. Soukka, T., Tenovuo, J., and Lenander-Lumikari, M. 1992. Fungicidal effect of human lactoferrin against Candida albicans. FEMS Microbiol. Lett. 69: 223-228.
13. Tansho, S., Tansho, T., Ikeda, T., Perera, P.D., Abe, S., and Yamaguchi, H. 1996. Augmentation of anti-Candida activity of lanoconazole by lysozyme. Jpn. J. Med. Mycol. (in press).
14. Uchida, K. 1991. Microdilution method to measure susceptibility of fungi to antifungal agents. Jpn. J. Med. Mycol. 32: 245-247 (in Japanese).
15. Vanden Bossche, H., Marichal, P., Odds, F.C., Le Jeune, L., and Coene, M.-C. 1992. Characterization of an azole-resistant Candida glabrata isolate. Antimicrob. Agents Chemother. 36: 2602-2610.
16. Wakabayashi, H., Hiratani, T., Uchida, K., and Yamaguchi, H. 1996. Antifungal spectrum and fungicidal mechanism of an N-terminal peptide of bovine lactoferrin. J. Infect. Chemother. 1: 185-189.